更多...
收起
This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):]  此内含子基因编码促黑素细胞激素(MSH)受体蛋白。编码的蛋白质,七跨膜G蛋白偶联受体,控制黑素生成。有两种类型的黑色素存在:褐黑素红和黑色真黑素。导致在功能丧失的基因突变与提高褐黑素的生产,从而导致更轻的皮肤和头发的颜色相关联。黑色素是光防护,但是褐黑素可以通过在UV辐射产生自由基有助于紫外线引起的皮肤损伤。 MSH的结合其受体激活受体并刺激黑色素合成。该受体是在太阳灵敏度的主要决定因素,并且是黑色素瘤和非黑色素瘤皮肤癌的遗传危险因素。超过30变异等位基因已被鉴定出与皮肤和头发的颜色相关,提供的证据表明该基因是在确定的正常人颜料变异的一个重要组成部分。 [由RefSeq的,2008年7月提供]
MC1R基因(以及对应的蛋白质)的细胞分布位置:
MC1R基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5 | 0.36 | 1 | 1 | CLINVAR_CTD_human_UNIPROT |
melanoma | 0.284044374 | 149 | 14 | BeFree_CTD_human_GAD_LHGDN |
Basal cell carcinoma | 0.25728386 | 7 | 1 | CTD_human_GAD_GWASCAT_LHGDN |
Oculocutaneous albinism type 2 | 0.243181358 | 3 | 0 | BeFree_CTD_human_GAD_ORPHANET |
Skin carcinoma | 0.126091273 | 8 | 1 | BeFree_GAD_GWASCAT |
Vitiligo | 0.12554839 | 4 | 3 | BeFree_CTD_human_GAD |
Freckles | 0.124734064 | 2 | 1 | GAD_GWASCAT |
Sunburn | 0.122367032 | 2 | 1 | GAD_GWASCAT |
Congenital melanocytic nevus | 0.120271442 | 1 | 0 | BeFree_ORPHANET |
Hyperalgesia | 0.12 | 1 | 0 | CTD_human |
Protein-Losing Enteropathies | 0.12 | 0 | 0 | CTD_human |
MELANOMA, CUTANEOUS MALIGNANT, 1 | 0.12 | 0 | 0 | CTD_human |
GIANT PIGMENTED HAIRY NEVUS | 0.12 | 0 | 0 | ORPHANET |
UV-INDUCED SKIN DAMAGE, SUSCEPTIBILITY TO | 0.12 | 0 | 2 | CLINVAR |
INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC (disorder) | 0.12 | 0 | 2 | CLINVAR |
Acute-Phase Reaction | 0.08 | 1 | 0 | RGD |
Skin Neoplasms | 0.069135442 | 27 | 0 | GAD_LHGDN |
Malignant neoplasm of skin | 0.013767591 | 43 | 6 | BeFree_GAD |
Multiple Sclerosis | 0.01246392 | 4 | 0 | BeFree_GAD_LHGDN |
Cutaneous Melanoma | 0.010510288 | 30 | 0 | BeFree_GAD |
Albinism, Oculocutaneous | 0.008358616 | 4 | 0 | BeFree_GAD_LHGDN |
Nevus | 0.006634157 | 9 | 0 | BeFree_GAD |
Squamous cell carcinoma | 0.006091273 | 6 | 1 | BeFree_GAD |
Malignant neoplasm of prostate | 0.005276948 | 3 | 0 | BeFree_GAD |
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder) | 0.004614512 | 17 | 10 | BeFree |
Experimental Organism Basal Cell Carcinoma | 0.004614512 | 17 | 4 | BeFree |
Erythema | 0.003181358 | 4 | 6 | BeFree_GAD |
Obesity | 0.002909916 | 3 | 0 | BeFree_GAD |
Parkinson Disease | 0.002909916 | 3 | 2 | BeFree_GAD |
Psoriasis | 0.002909916 | 2 | 0 | BeFree_GAD |
Melanoma, Amelanotic | 0.002909916 | 3 | 0 | BeFree_GAD |
Lymphoma, Follicular | 0.002638474 | 1 | 0 | BeFree_GAD |
Diffuse Large B-Cell Lymphoma | 0.002638474 | 1 | 0 | BeFree_GAD |
Vulvar Vestibulitis | 0.002638474 | 1 | 0 | BeFree_GAD |
Carcinoma, Papillary | 0.002367032 | 1 | 0 | GAD |
Lymphoma, Non-Hodgkin | 0.002367032 | 1 | 0 | GAD |
Neoplasms, Multiple Primary | 0.002367032 | 1 | 0 | GAD |
Neoplasms, Radiation-Induced | 0.002367032 | 1 | 0 | GAD |
Photosensitivity Disorders | 0.002367032 | 1 | 0 | GAD |
Thyroid Neoplasm | 0.002367032 | 1 | 0 | GAD |
Epstein-Barr Virus Infections | 0.002367032 | 1 | 0 | GAD |
Follicular thyroid carcinoma | 0.002367032 | 1 | 0 | GAD |
Solar Erythema | 0.002367032 | 1 | 0 | GAD |
Structure showing abnormal deposition of pigment (morphologic abnormality) | 0.002367032 | 1 | 0 | GAD |
Melanocytic nevus | 0.002171535 | 8 | 0 | BeFree |
Benign melanocytic nevus | 0.001628651 | 6 | 0 | BeFree |
Absence of pain sensation | 0.001357209 | 5 | 0 | BeFree |
Melanocytic nevus of skin | 0.001357209 | 5 | 0 | BeFree |
Neoplasm Metastasis | 0.001085767 | 4 | 0 | BeFree |
Carcinogenesis | 0.001085767 | 4 | 0 | BeFree |
Hereditary Melanoma | 0.001085767 | 4 | 0 | BeFree |
Lentigo | 0.000814326 | 3 | 2 | BeFree |
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 0.000814326 | 3 | 3 | BeFree |
Albinism | 0.000542884 | 2 | 0 | BeFree |
Pallor | 0.000542884 | 2 | 2 | BeFree |
Piebaldism | 0.000542884 | 2 | 0 | BeFree |
Angelman Syndrome | 0.000542884 | 2 | 0 | BeFree |
Prostate carcinoma | 0.000542884 | 2 | 0 | BeFree |
Anxiety Disorders | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of breast | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of thyroid | 0.000271442 | 1 | 0 | BeFree |
Hodgkin Disease | 0.000271442 | 1 | 0 | BeFree |
Actinic keratosis | 0.000271442 | 1 | 0 | BeFree |
Mesothelioma | 0.000271442 | 1 | 0 | BeFree |
Neck Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Pain | 0.000271442 | 1 | 0 | BeFree |
Pheochromocytoma | 0.000271442 | 1 | 5 | BeFree |
Dermatologic disorders | 0.000271442 | 1 | 0 | BeFree |
Skin lesion | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of bone | 0.000271442 | 1 | 0 | BeFree |
Cicatrix, Hypertrophic | 0.000271442 | 1 | 0 | BeFree |
Hypopigmentation disorder | 0.000271442 | 1 | 0 | BeFree |
Uveal melanoma | 0.000271442 | 1 | 0 | BeFree |
Superficial spreading malignant melanoma of skin | 0.000271442 | 1 | 0 | BeFree |
Thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of skin | 0.000271442 | 1 | 0 | BeFree |
Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
skin damage | 0.000271442 | 1 | 0 | BeFree |
Spot pigmented | 0.000271442 | 1 | 2 | BeFree |
Skin Pigmentation Disorder | 0.000271442 | 1 | 0 | BeFree |
Hypotrichosis simplex | 0.000271442 | 1 | 1 | BeFree |
ALBINOIDISM, OCULOCUTANEOUS, AUTOSOMAL DOMINANT | 0.000271442 | 1 | 0 | BeFree |
Lentigo maligna melanoma | 0.000271442 | 1 | 1 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。